keyword
MENU ▼
Read by QxMD icon Read
search

rheumatol arthritis

keyword
https://www.readbyqxmd.com/read/28960941/two-nih-grants-omitted-from-grant-support-statement-in-the-article-by-kalampokis-et-al-arthritis-rheumatol-january-2017
#1
(no author information available yet)
No abstract text is available yet for this article.
October 2017: Arthritis & Rheumatology
https://www.readbyqxmd.com/read/28960940/errors-in-the-format-of-the-global-pain-score-visual-analog-scale-in-the-article-by-roman-blas-et-al-arthritis-rheumatol-january-2017
#2
(no author information available yet)
No abstract text is available yet for this article.
October 2017: Arthritis & Rheumatology
https://www.readbyqxmd.com/read/28828533/anti-m%C3%A3-llerian-hormone-and-ovarian-reserve-in-systemic-lupus-erythematosus
#3
Nádia Filipa Esteves Martins, Maria Inês Seixas, Joaquim Polido Pereira, Maria Manuela Costa, João Eurico Fonseca
Systemic lupus erythematosus (SLE) is a chronic immune-mediated inflammatory disease that affects predominantly females during childbearing age (Lateef and Petri Best Pract Res Clin Rheumatol 27(3):435-447, 2013). Fertility in SLE patients is considered to be normal (Clowse et al. Arthritis Care Res (Hoboken) 64(5):668-674, 2012; Ekblom-Kullberg et al. Scand J Rheumatol 38:375-380, 2009) but several known factors may negatively influence fertility. Immune mechanisms are also thought to be an important cause of premature ovarian senescence, characterized by reduced ovarian reserve markers such as anti-Müllerian hormone (AMH) (Oktem et al...
August 22, 2017: Clinical Rheumatology
https://www.readbyqxmd.com/read/28737994/impact-of-a-patient-support-program-on-patient-adherence-to-adalimumab-and-direct-medical-costs-in-crohn-s-disease-ulcerative-colitis-rheumatoid-arthritis-psoriasis-psoriatic-arthritis-and-ankylosing-spondylitis
#4
David T Rubin, Manish Mittal, Matthew Davis, Scott Johnson, Jingdong Chao, Martha Skup
BACKGROUND: AbbVie provides a free-to-patient patient support program (PSP) to assist adalimumab-treated patients with medication costs, nurse support, injection training, pen disposal, and medication reminders. The impact of these services on patient adherence to adalimumab and direct medical costs associated with autoimmune disease has not been assessed. OBJECTIVE: To quantify the relationship between participation in a PSP and outcomes (adalimumab adherence, persistence, and direct medical costs) in patients initiating adalimumab treatment...
August 2017: Journal of Managed Care & Specialty Pharmacy
https://www.readbyqxmd.com/read/28371559/middle-initial-omitted-from-author-name-in-the-article-by-felson-et-al-arthritis-rheumatol-february-2017
#5
(no author information available yet)
No abstract text is available yet for this article.
April 2017: Arthritis & Rheumatology
https://www.readbyqxmd.com/read/28239991/heterozygosity-of-the-721-221-b-51-01-cell-line-used-in-the-study-by-guasp-et-arthritis-rheumatol-february-2016
#6
(no author information available yet)
No abstract text is available yet for this article.
March 2017: Arthritis & Rheumatology
https://www.readbyqxmd.com/read/27785909/errors-in-table-3-of-the-article-by-domsic-et-al-arthritis-rheumatol-april-2016
#7
(no author information available yet)
No abstract text is available yet for this article.
November 2016: Arthritis & Rheumatology
https://www.readbyqxmd.com/read/27558405/financial-disclosure-information-on-one-author-in-the-article-by-cartin-ceba-et-al-arthritis-rheumatol-june-2016
#8
(no author information available yet)
No abstract text is available yet for this article.
September 2016: Arthritis & Rheumatology
https://www.readbyqxmd.com/read/27107516/corrigendum-to-risk-of-infection-with-biologic-antirheumatic-therapies-in-patients-with-rheumatoid-arthritis-best-pract-res-clin-rheumatol-29-2-2015-290-305
#9
Manjari Lahiri, William G Dixon
No abstract text is available yet for this article.
December 2015: Best Practice & Research. Clinical Rheumatology
https://www.readbyqxmd.com/read/27023361/financial-disclosure-information-inadvertently-omitted-by-the-journal-in-the-editorial-by-sattar-and-mcinnes-arthritis-rheumatol-march-2016
#10
(no author information available yet)
No abstract text is available yet for this article.
April 2016: Arthritis & Rheumatology
https://www.readbyqxmd.com/read/26808829/errata
#11
(no author information available yet)
Errors in Table 3 and 4 of the Article by Solomon et al (Arthritis Rheumatol, August 2015).
February 2016: Arthritis & Rheumatology
https://www.readbyqxmd.com/read/26808828/errata
#12
(no author information available yet)
Misspelled Author Name in the Article by Neogi et al (Arthritis Rheumatol, October 2015).
February 2016: Arthritis & Rheumatology
https://www.readbyqxmd.com/read/26508467/amended-95-confidence-intervals-in-tables-in-the-article-by-jani-et-al-arthritis-rheumatol-august-2015
#13
(no author information available yet)
No abstract text is available yet for this article.
November 2015: Arthritis & Rheumatology
https://www.readbyqxmd.com/read/26340306/erratum
#14
Heidi Jacobe, Chul Ahn, Frank C Arnett, John D Reveille
In the article by Jacobe et al published in the November 2014 issue of Arthritis & Rheumatology (pages 3170-3177), a row listing the (nonexistent) allele DQA1*03:00 was inadvertently included in Tables 3, 5, and 6, as the result of a typographical error.
March 2015: Arthritis & Rheumatology
https://www.readbyqxmd.com/read/26309053/misidentified-band-in-figure-in-the-article-by-zhang-et-al-arthritis-rheumatol-march-2015
#15
(no author information available yet)
No abstract text is available yet for this article.
September 2015: Arthritis & Rheumatology
https://www.readbyqxmd.com/read/26309052/incorrect-figure-in-the-article-by-wang-et-al-arthritis-rheumatol-january-2014
#16
(no author information available yet)
No abstract text is available yet for this article.
September 2015: Arthritis & Rheumatology
https://www.readbyqxmd.com/read/26174879/comorbidity-indices-for-clinical-trials-adaptation-of-two-existing-indices-for-use-with-the-freedom-trial-in-women-with-postmenopausal-osteoporosis
#17
RANDOMIZED CONTROLLED TRIAL
S L Silverman, A Wang, L Cheng, Y Yang, C Libanati, M Geller, A Grauer, M Nevitt, D Revicki, H N Viswanathan
UNLABELLED: Two comorbidity indices were adapted for use in the FREEDOM trial and significantly correlated with the number of medications and impaired health status at baseline. The indices have applications for the analysis of clinical trial data and would allow for the appropriate adjustment of comorbidities when evaluating clinical trial outcomes. INTRODUCTION: The purpose of this study is to adapt two published comorbidity indices for use with the FREEDOM clinical trial evaluating postmenopausal women with osteoporosis...
January 2016: Osteoporosis International
https://www.readbyqxmd.com/read/26013245/errors-relating-to-study-controls-and-criteria-naming-in-the-editorial-by-wolfe-arthritis-rheumatol-february-2015
#18
(no author information available yet)
No abstract text is available yet for this article.
June 2015: Arthritis & Rheumatology
https://www.readbyqxmd.com/read/25227901/clinical-trials-documenting-the-efficacy-of-low-dose-glucocorticoids-in-rheumatoid-arthritis
#19
Theodore Pincus, Maurizio Cutolo
Twelve clinical trials have documented that prednisone or prednisolone in doses of 10 mg/day or less is efficacious to improve function, maintain status and/or slow radiographic progression in patients with rheumatoid arthritis (RA). An early trial reported by de Andrade et al. [Ann Rheum Dis 1964;23:158-162] in 1964 indicated that 5 mg of prednisolone at night was preferred to 5 mg of prednisone in the morning. Harris et al. [J Rheumatol 1983;10:713-721] documented the efficacy of 5 mg/day of prednisone in a non-double-blind trial in 1983...
2015: Neuroimmunomodulation
https://www.readbyqxmd.com/read/24634205/longterm-safety-and-effectiveness-of-the-anti-interleukin-6-receptor-monoclonal-antibody-tocilizumab-in-patients-with-systemic-juvenile-idiopathic-arthritis-in-japan
#20
RANDOMIZED CONTROLLED TRIAL
Shumpei Yokota, Tomoyuki Imagawa, Masaaki Mori, Takako Miyamae, Syuji Takei, Naomi Iwata, Hiroaki Umebayashi, Takuji Murata, Mari Miyoshi, Minako Tomiita, Norihiro Nishimoto, Tadamitsu Kishimoto
OBJECTIVE: To assess the longterm safety and effectiveness of tocilizumab (TCZ) in systemic-onset juvenile idiopathic arthritis (sJIA). METHODS: The longterm extension phase of 2 pivotal studies (phase II with 11 patients and phase III with 56 patients) in patients with active sJIA was analyzed. Patients received open-label TCZ (8 mg/kg, every 2 weeks) without concomitant use of disease-modifying antirheumatic drugs. RESULTS: In total, 67 patients were enrolled...
April 2014: Journal of Rheumatology
keyword
keyword
73099
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"